How Europe's busiest PrEP clinics are simplifying care and reaching new populations
Leading community-led PrEP services are rethinking how they deliver services while reaching beyond their traditional user base. Facing waiting lists of thousands, the clinics are streamlining care
and developing new strategies to engage trans people and migrant men who have sex with men. These were among the approaches shared at the 2nd European Workshop on Breaking PrEP Barriers, held in
Barcelona last week.
>> Read more
Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible
While 41% of HIV-negative people from sexual and gender minorities in the UK are taking PrEP, figures drop to below 15% in most of the Balkans and eastern Europe, according to results from the
European MSM Internet Survey (EMIS) 2024. Too many people stop taking PrEP when they still need it, and this is often due to access difficulties, Professor Kai Jonas of the University of Maastricht
told the 2nd European Workshop on Breaking PrEP Barriers, organised by BCN Checkpoint in Barcelona last week.
>> Read more
Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study
An antibody from a Tanzanian woman discovered during screening for anti-HIV antibodies shows a strong therapeutic potential in a preclinical study. Named 04_A06, it neutralised (blocked) 97.3% of
over 300 HIV strains tested, and blocked 77% of viruses resistant to other antibodies. In humanised mice – designed to have an immune system like ours – the antibody completely suppressed viral load
after stopping treatment for more than a month.
>> Read more